From Our Affiliates

Tag: Genzyme

A total of 43 posts are filed under Genzyme
Screen Shot 2014-12-05 at 9.06.05 AM
New RARE Toolkit: Pediatric Palliative Care
Today Global Genes announces its newest educational toolkit on pediatric palliative care. This toolkit, created in partnership with the… Continue Reading
PDL BioPharma Buys Share of Cerdelga Royalties for $65.6M
Source. PDL BioPharma said yesterday it acquired a portion of the University of Michigan (U-M) worldwide royalty interest in Cerdelga™… Continue Reading
New RARE Toolkit “Searching For Answers: Contacting Biopharmaceutical Companies Effectively”
“I can do that?” This is the question patients ask when it comes to the possibility of working directly with biopharmaceutical… Continue Reading
Genzyme Providing $900K Towards Gene Therapy Research for Childhood Blindness
Genzyme is entering the fields of ophthalmology and gene therapy.  Today, the company announced they are providing $900,000 in funding to… Continue Reading
The Balancing Act®’s Behind The Mystery on Lifetime Talks Pompe Disease This Tuesday 6/3
Behind the Mystery of Pompe Disease It’s a devastating medical mystery: random symptoms that present in many common diseases; low… Continue Reading
Boston Marathon: Genzyme Runners Supporting ‘Rare’ Cause
By Anamika Roy Daily News Staff A team of Genzyme employees is running for a “rare” cause on Marathon Monday. In partnership with the… Continue Reading
“What Are Biomarkers?” a Webinar by the AMDA and Genzyme on April 15th
Learn about Biomarkers – what they are, why they are important, and what Genzyme is doing to understand Biomarkers in Pompe disease.… Continue Reading
1 2 3 7

Follow us on Twitter